Elizabeth Arthur, MD
Dermatology · Rochester, NYNPI 1346219953
Payments from drug & device makers
Across 473 payments — averaging $27.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Johnson & Johnson$571
- Sun Pharmaceutical Industries Inc.$560
- Pfizer$456
- Novartis$442
- Sanofi$414
- plus $3K from 22 others
What the payments were for
- Speaking & faculty fees$5,00038%
- Food & beverage$8,04462%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 146 | $7,288 |
| Johnson & Johnson | 23 | $571 |
| Sun Pharmaceutical Industries Inc. | 30 | $560 |
| Pfizer | 31 | $456 |
| Novartis | 25 | $442 |
| Sanofi | 14 | $414 |
| UCB, Inc. | 24 | $400 |
| Dermavant Sciences, Inc. | 52 | $384 |
| Lilly USA, LLC | 15 | $332 |
| Amgen | 12 | $324 |
| E.r. Squibb & Sons, L.L.C. | 14 | $305 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $298 |
| Galderma Laboratories, L.p. | 12 | $201 |
| Regeneron Healthcare Solutions, Inc. | 5 | $133 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $126 |
| LEO Pharma Inc. | 6 | $114 |
| Arcutis Biotherapeutics, Inc. | 6 | $114 |
| Incyte Corporation | 4 | $92 |
| Dermira, Inc. | 5 | $90 |
| Prugen, Inc. Pharmaceuticals | 20 | $71 |
| VYNE Pharmaceuticals Inc. | 3 | $51 |
| Mayne Pharma Commercial LLC | 3 | $50 |
| Bristol Myers Squibb | 2 | $48 |
| Sandoz | 2 | $43 |
| Strata Skin Sciences, Inc. | 4 | $39 |
| Biofrontera Inc. | 2 | $38 |
| DUSA Pharmaceuticals, Inc. | 2 | $36 |
| Almirall LLC | 1 | $23 |
How this compares
$13,044 in reported general payments places this provider in the 75th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 19 | $1,257 |
| Metronidazole | 18 | $1,002 |
| Clindamycin Phosphate | 17 | $897 |
| Clobetasol Propionate | 20 | $779 |
| Mometasone Furoate | 38 | $704 |
| ValacyclovirValacyclovir Hcl | 11 | $323 |
| Ketoconazole | 14 | $279 |
| Mupirocin | 19 | $142 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rochester
- John TuRochester$5.4M
- Lisa BeckRochester$2.3M
- Anna DebenedettoRochester$749K
- Mary Gail MercurioRochester$655K
- Emma GuttmanNew York$35.3M
- Saakshi KhattriNew York$15.4M
- James KruegerNew York$6.3M
- Michael CameronNew York$5.8M
- Mark LebwohlNew York$5.8M
- Andrew AlexisNew York$5.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.